Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.224
-0.014 (-5.68%)
At close: Apr 28, 2026, 4:00 PM EDT
0.207
-0.018 (-7.81%)
Pre-market: Apr 29, 2026, 5:35 AM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $2.47 million as of April 29, 2026. Its market cap has decreased by -83.26% in one year.
Market Cap
2.47M
Enterprise Value
-561.76K
1-Year Change
-83.26%
Ranking
Category
Stock Price
$0.22
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $2.47M, a decrease of -99.10%. That is a compound annual growth rate of -64.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.47M | -71.10% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 3.18M |
| GeoVax Labs | 3.15M |
| Decoy Therapeutics | 2.89M |
| Oragenics | 2.78M |
| Silexion Therapeutics | 2.61M |
| Scinai Immunotherapeutics | 2.56M |
| HCW Biologics | 2.53M |
| Bone Biologics | 2.44M |